AlphaTON Capital Corp.(ATON)Earnings, Financials & Key Ratios
ATON•NASDAQ
$0.25
Price updated Jul 7, 2026
SectorFinancial ServicesIndustryAsset ManagementSub-IndustryNon-core and special situations vehicles
AboutAlphaTON Capital Corp. is the rebranded entity formerly known as Portage Biotech Inc., a clinical-stage immuno-oncology company transitioning into a digital asset treasury model focused on accumulating and staking Toncoin (TON). AlphaTON intends to invest significantly in TON tokens, targeting a Long-Term TON treasury of approximately US $100 million.Show more
- EBITDA-$7M+59.4%
- Net Income-$7M+91.0%
- EPS (Diluted)-5.72-54.6%
- ROE-540.93%-182.6%
ATON Price & Volume
AlphaTON Capital Corp. (ATON) stock price & volume — 10-year historical chart
Loading chart...
AlphaTON Capital Faces Severe Operational Liquidity Crisis
Investment Thesis • Updated 2026Q2
VerdictNegative
Growth:Contracting
Profitability:Negative
Financial:Vulnerable
Cash Flow:Burning
Primary Risk:Capital structure dilution risk
Key Thesis Takeaways
- AlphaTON Capital Corp.
- is currently navigating a precarious transition from clinical-stage biotech to a digital asset treasury model, characterized by a complete absence of revenue generation over the last ten quarters.
- The firm's reliance on stock-based compensation, which reached $984.0K in 2026Q2, masks significant operational losses and creates substantial dilution risk for existing shareholders.
- Investors should remain cautious as the company's dwindling cash reserves of $183.0K appear insufficient to support its stated $100 million treasury target.
Verdict Logic
the company's cash position has plummeted to $183.0K, leaving it with a dangerously narrow buffer to cover ongoing administrative costs and sustain its public listing.
ATON Growth Metrics
AlphaTON Capital Corp. (ATON) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years-
TTM-
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM70.73%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-106.45%
Return on Capital
10 Years-53.23%
5 Years-61.83%
3 Years-97.79%
Last Year-246.24%
Peers Comparison
Key metrics vs top competitors for AlphaTON Capital Corp. (ATON)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $0.25 | $620.48K | -0.04 | — | — | -540.93% | — | |
| $23.51 | $1.46B | 12.37 | 50.13% | 50.89% | 11.68% | — | |
| $15.64 | $622.82M | 3.28 | -20.47% | 173.56% | 34.04% | — | |
| $5.08 | $110.06M | 9.58 | -39.74% | -72.87% | -2.9% | — | |
| $4.75 | $192.85M | 3.89 | 36.55% | -19.55% | -3.39% | — | |
| $8.30 | $112.2M | 8.74 | 148.14% | 41.96% | 7.25% | — |
Compare ATON vs Peers
AlphaTON Capital Corp. (ATON) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Get notified when ATON posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
ATON Frequently Asked Questions
AlphaTON Capital Corp. (ATON) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Is ATON profitable?
AlphaTON Capital Corp. (ATON) reported a net loss of $19.7M for fiscal year 2025.
Dividend & Returns
What is ATON's return on equity?
AlphaTON Capital Corp. (ATON) has a return on equity (ROE) of -540.9%. Negative ROE indicates the company is unprofitable.
What is AlphaTON Capital Corp.'s free cash flow?
AlphaTON Capital Corp. (ATON) had negative free cash flow of $3.6M in fiscal year 2025, likely due to heavy capital investments.